Pharmacelsus - Preclinical Services
Your partner for preclinical drug discovery and developtment
Pharmacelsus, Germany´s market-leading early stage CRO, plans, organizes and realizes customized preclinical studies for more than 20 years. Our assays meet national and international regulatory demands while using our unique consultative approach to serve more than 120+ satisfied customers who rely on our expertise, experience and passion for science.
Hit-to-Lead and Lead Optimization
The Pharmacelsus portfolio covers the complete drug discovery and development testing program for small molecules and peptides in vitro, in vivo, ex vivo as well as G(C)LP and non-GLP bioanalysis. Structural, physicochemical and functional characterization of Biopharmaceuticals (e.g. Antibodies, ADCs, etc.) complements our comprehensive portfolio.
Your direct contact
Dr. Daniel Da Costa
BD Director Preclinical Services Europe
Our Flyers
GBA Group Pharma Sites
Mit dem Laden des Contents akzeptieren Sie Datenschutzbestimmungen von der GBA Group
Mehr erfahrenPharmacelsus - Preclinical services
Pharmacelsus GmbH
Science Park 2
66123 Saarbrücken
Germany
Fax +49 681 3946 - 7511
Google Maps
Member of the GBA Group since 2017.